共 50 条
- [31] A phase I trial of rituximab (anti-CD20) for treatment of systemic lupus erythematosus. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S446 - S447
- [32] A phase I trial of rituximab (anti-CD20) for treatment of systemic lupus erythematosus. ARTHRITIS AND RHEUMATISM, 2003, 48 (12): : 3659 - 3659
- [33] Anti-CD20 monoclonal antibody (Rituximab) and cidofovir as successful treatment of an EBV-associated lymphoma with CNS involvement ONKOLOGIE, 2001, 24 (05): : 491 - 494
- [36] A Rapidly Progressive, Life-Threatening Postpartum Hemorrhage Successful Treatment With Anti-CD-20 Monoclonal Antibody OBSTETRICS AND GYNECOLOGY, 2009, 114 (02): : 417 - 419
- [39] Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-cd20 monoclonal antibody rituximab CLINICAL AND LABORATORY HAEMATOLOGY, 2006, 28 (01): : 57 - 59
- [40] Successful Treatment of EBV PTLD with CNS Lymphomas with the Monoclonal Anti-CD20 Antibody Rituximab ONKOLOGIE, 2008, 31 (12): : 691 - 693